Sebastopol, CA, United States of America

Alison Hannah

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Alison Hannah – Innovations in Cancer Treatment

Introduction

Alison Hannah, an innovative inventor based in Sebastopol, California, has made significant contributions to the field of cancer treatment through her groundbreaking patents. With a total of three patents to her name, she has been at the forefront of developing methods that enhance the efficacy of cancer therapies, particularly for breast cancer and solid tumors.

Latest Patents

One of Alison's latest patents is a method for assessing and predicting the efficacy of breast cancer treatment using long-acting topoisomerase I inhibitors such as SN-38 or irinotecan. This method correlates the level of tumor markers, such as CA27.29, with the response of cancer to the treatment, providing a novel approach for predicting and assessing therapeutic efficacy.

Additionally, Alison has developed methods involving the treatment of various cancers, utilizing the compound 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one. These methods are particularly effective against solid tumors and leukemias, including those affecting the prostate, colorectal system, breast, and more. Furthermore, she has devised methodologies for measuring the compound and determining a metabolic profile, advancing the realm of personalized medicine in oncology.

Career Highlights

Throughout her career, Alison has worked with prominent companies, including Nektar Therapeutics and Novartis Vaccines & Diagnostics GmbH. Her experience in these organizations has greatly influenced her innovative approach to cancer research and therapy development.

Collaborations

Alison has collaborated with notable professionals in the field, including Yen Lin Chia and Ute Hoch. These partnerships have allowed her to enhance her research methodologies and broaden the impact of her innovations in cancer treatment.

Conclusion

Alison Hannah stands out as a prominent figure in the field of cancer research and treatment innovation. Her patented methods not only demonstrate her ingenuity as an inventor but also offer hope for improved therapeutic strategies in the fight against cancer. With her dedication and continued collaboration in research, Alison’s contributions promise to play a crucial role in advancing oncology and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…